{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:16:22Z","timestamp":1790766982019,"version":"4.1.0"},"reference-count":23,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1002\/pbc.26035","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T21:25:13Z","timestamp":1462224313000},"page":"1394-1399","source":"Crossref","is-referenced-by-count":11,"title":["<i>CXCR4<\/i>Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia\/Lymphoma Study Group"],"prefix":"10.1002","volume":"63","author":[{"given":"Hidemasa","family":"Matsuo","sequence":"first","affiliation":[{"name":"Department of Human Health Sciences; Kyoto University; Kyoto Japan"},{"name":"Department of Clinical Laboratory; Kyoto University Hospital; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Human Health Sciences; Kyoto University; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tomizawa","sequence":"additional","affiliation":[{"name":"Division of Leukemia and Lymphoma; Children's Cancer Center; National Center for Child Health and Development; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko Moriya","family":"Saito","sequence":"additional","affiliation":[{"name":"Clinical Research Center; National Nagoya Hospital; Aichi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Kiyokawa","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology Research; National Research Institute for Child Health and Development; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Horibe","sequence":"additional","affiliation":[{"name":"Clinical Research Center; National Nagoya Hospital; Aichi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Nishinaka-Arai","sequence":"additional","affiliation":[{"name":"Department of Human Health Sciences; Kyoto University; Kyoto Japan"},{"name":"Department of Clinical Application; Center for iPS Cell Research and Application; Kyoto University; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Tokumasu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Kyoto University; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Human Health Sciences; Kyoto University; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Kamikubo","sequence":"additional","affiliation":[{"name":"Department of Human Health Sciences; Kyoto University; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; National Hospital Organization; Fukuoka-Higashi Medical Center; Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitoshi","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; St. Marianna University School of Medicine; Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Taga","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Shiga University of Medical Science; Shiga Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Tawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Osaka National Hospital; Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Taki","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnostics and Therapeutics; Kyoto Prefectural University of Medicine; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pharmacoepidemiology; Kyoto University; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souichi","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Human Health Sciences; Kyoto University; Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,2]]},"reference":[{"key":"10.1002\/pbc.26035-BIB0001|pbc26035-cit-0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1440-1827.2010.02548.x","article-title":"CXCR4 and cancer","volume":"60","author":"Furusato","year":"2010","journal-title":"Pathol Int"},{"key":"10.1002\/pbc.26035-BIB0002|pbc26035-cit-0002","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"10.1002\/pbc.26035-BIB0003|pbc26035-cit-0003","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20041385","article-title":"Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist","volume":"201","author":"Broxmeyer","year":"2005","journal-title":"J Exp Med"},{"key":"10.1002\/pbc.26035-BIB0004|pbc26035-cit-0004","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/pbc.25467","article-title":"Mobilisation of haematopoietic stem cells in paediatric patients prior to autologous transplantation following administration of plerixafor and G-CSF","volume":"62","author":"Patel","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.26035-BIB0005|pbc26035-cit-0005","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.leu.2402608","article-title":"Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins","volume":"16","author":"Konopleva","year":"2002","journal-title":"Leukemia"},{"key":"10.1002\/pbc.26035-BIB0006|pbc26035-cit-0006","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1158\/1541-7786.MCR-13-0114","article-title":"Dynamic chemotherapy-induced upregulation of CXCR4 expression: A mechanism of therapeutic resistance in pediatric AML","volume":"11","author":"Sison","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1002\/pbc.26035-BIB0007|pbc26035-cit-0007","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2141.2001.03164.x","article-title":"High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia","volume":"115","author":"Crazzolara","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1002\/pbc.26035-BIB0008|pbc26035-cit-0008","doi-asserted-by":"crossref","first-page":"e27042","DOI":"10.1371\/journal.pone.0027042","article-title":"Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF-1\/CXCR4 axis","volume":"6","author":"Kato","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/pbc.26035-BIB0009|pbc26035-cit-0009","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1182\/blood-2008-05-158311","article-title":"Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML","volume":"113","author":"Zeng","year":"2009","journal-title":"Blood"},{"key":"10.1002\/pbc.26035-BIB0010|pbc26035-cit-0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1182\/blood-2015-02-628677","article-title":"Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy","volume":"126","author":"Cho","year":"2015","journal-title":"Blood"},{"key":"10.1002\/pbc.26035-BIB0011|pbc26035-cit-0011","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","article-title":"A phase 1\/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"},{"key":"10.1002\/pbc.26035-BIB0012|pbc26035-cit-0012","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1182\/blood-2004-02-0566","article-title":"Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia","volume":"104","author":"Rombouts","year":"2004","journal-title":"Blood"},{"key":"10.1002\/pbc.26035-BIB0013|pbc26035-cit-0013","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"10.1002\/pbc.26035-BIB0014|pbc26035-cit-0014","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.22510","article-title":"Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype","volume":"109","author":"Konoplev","year":"2007","journal-title":"Cancer"},{"key":"10.1002\/pbc.26035-BIB0015|pbc26035-cit-0015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.leukres.2008.10.014","article-title":"Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia","volume":"33","author":"Tavernier-Tardy","year":"2009","journal-title":"Leuk Res"},{"key":"10.1002\/pbc.26035-BIB0016|pbc26035-cit-0016","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/cyto.b.21156","article-title":"CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia","volume":"86","author":"Mannelli","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1002\/pbc.26035-BIB0017|pbc26035-cit-0017","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00277-015-2442-8","article-title":"VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia","volume":"94","author":"Bae","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1002\/pbc.26035-BIB0018|pbc26035-cit-0018","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2015.62.8289","article-title":"Collaborative efforts driving progress in pediatric acute myeloid leukemia","volume":"33","author":"Zwaan","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.26035-BIB0019|pbc26035-cit-0019","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.3324\/haematol.2014.107128","article-title":"EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia","volume":"99","author":"Matsuo","year":"2014","journal-title":"Haematologica"},{"key":"10.1002\/pbc.26035-BIB0020|pbc26035-cit-0020","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1038\/bcj.2014.47","article-title":"Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: A report from the Japanese Pediatric Leukemia\/Lymphoma Study Group","volume":"4","author":"Matsuo","year":"2014","journal-title":"Blood Cancer J"},{"key":"10.1002\/pbc.26035-BIB0021|pbc26035-cit-0021","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/leu.2015.121","article-title":"Adverse prognostic impact of KIT mutations in childhood CBF-AML: The results of the Japanese Pediatric Leukemia\/Lymphoma Study Group AML-05 trial","volume":"29","author":"Tokumasu","year":"2015","journal-title":"Leukemia"},{"key":"10.1002\/pbc.26035-BIB0022|pbc26035-cit-0022","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12185-013-1429-2","article-title":"Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: A report from the Japanese Pediatric Leukemia\/Lymphoma Study Group","volume":"98","author":"Tomizawa","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1002\/pbc.26035-BIB0023|pbc26035-cit-0023","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.leukres.2004.04.018","article-title":"Interaction of bone marrow stromal cells with lymphoblasts and effects of predinsolone on cytokine expression","volume":"29","author":"Wu","year":"2005","journal-title":"Leuk Res"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.26035","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.26035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T15:59:10Z","timestamp":1533571150000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pbc.26035"}},"subtitle":["Prognostic Significance of<i>CXCR4<\/i>+ in Pediatric AML"],"short-title":[],"issued":{"date-parts":[[2016,5,2]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.26035","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,2]]}}}